These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 18308254)

  • 1. Activation of the PI3-K/AKT pathway and implications for radioresistance mechanisms in head and neck cancer.
    Bussink J; van der Kogel AJ; Kaanders JH
    Lancet Oncol; 2008 Mar; 9(3):288-96. PubMed ID: 18308254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The PI3-K/AKT-pathway and radiation resistance mechanisms in non-small cell lung cancer.
    Schuurbiers OC; Kaanders JH; van der Heijden HF; Dekhuijzen RP; Oyen WJ; Bussink J
    J Thorac Oncol; 2009 Jun; 4(6):761-7. PubMed ID: 19404218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improving chemoradiation efficacy by PI3-K/AKT inhibition.
    Stegeman H; Span PN; Kaanders JH; Bussink J
    Cancer Treat Rev; 2014 Dec; 40(10):1182-91. PubMed ID: 25312653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistent activation of the Akt pathway in head and neck squamous cell carcinoma: a potential target for UCN-01.
    Amornphimoltham P; Sriuranpong V; Patel V; Benavides F; Conti CJ; Sauk J; Sausville EA; Molinolo AA; Gutkind JS
    Clin Cancer Res; 2004 Jun; 10(12 Pt 1):4029-37. PubMed ID: 15217935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutant epidermal growth factor receptor signaling down-regulates p27 through activation of the phosphatidylinositol 3-kinase/Akt pathway in glioblastomas.
    Narita Y; Nagane M; Mishima K; Huang HJ; Furnari FB; Cavenee WK
    Cancer Res; 2002 Nov; 62(22):6764-9. PubMed ID: 12438278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concomitant inactivation of the epidermal growth factor receptor, phosphatidylinositol 3-kinase/Akt and Janus tyrosine kinase 2/signal transducer and activator of transcription 3 signalling pathways in cardiotoxin III-treated A549 cells.
    Su JC; Lin KL; Chien CM; Chuang PW; Chang LS; Lin SR
    Clin Exp Pharmacol Physiol; 2010 Aug; 37(8):833-40. PubMed ID: 20456425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bradykinin-induced p42/p44 MAPK phosphorylation and cell proliferation via Src, EGF receptors, and PI3-K/Akt in vascular smooth muscle cells.
    Yang CM; Lin MI; Hsieh HL; Sun CC; Ma YH; Hsiao LD
    J Cell Physiol; 2005 Jun; 203(3):538-46. PubMed ID: 15573401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphatidylinositol 3-kinase/Akt signaling as a key mediator of tumor cell responsiveness to radiation.
    Toulany M; Rodemann HP
    Semin Cancer Biol; 2015 Dec; 35():180-90. PubMed ID: 26192967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TC21 mediates transformation and cell survival via activation of phosphatidylinositol 3-kinase/Akt and NF-kappaB signaling pathway.
    Rong R; He Q; Liu Y; Sheikh MS; Huang Y
    Oncogene; 2002 Feb; 21(7):1062-70. PubMed ID: 11850823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lovastatin inhibits EGFR dimerization and AKT activation in squamous cell carcinoma cells: potential regulation by targeting rho proteins.
    Zhao TT; Le Francois BG; Goss G; Ding K; Bradbury PA; Dimitroulakos J
    Oncogene; 2010 Aug; 29(33):4682-92. PubMed ID: 20562912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intestinal epithelial cancer cell anoikis resistance: EGFR-mediated sustained activation of Src overrides Fak-dependent signaling to MEK/Erk and/or PI3-K/Akt-1.
    Demers MJ; Thibodeau S; Noël D; Fujita N; Tsuruo T; Gauthier R; Arguin M; Vachon PH
    J Cell Biochem; 2009 Jul; 107(4):639-54. PubMed ID: 19479902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of hypoxia/reoxygenation-induced oxidative stress in HGF-stimulated antiapoptotic signaling: role of PI3-K and Akt kinase upon rac1.
    Ozaki M; Haga S; Zhang HQ; Irani K; Suzuki S
    Cell Death Differ; 2003 May; 10(5):508-15. PubMed ID: 12728249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoxia activates a platelet-derived growth factor receptor/phosphatidylinositol 3-kinase/Akt pathway that results in glycogen synthase kinase-3 inactivation.
    Chen EY; Mazure NM; Cooper JA; Giaccia AJ
    Cancer Res; 2001 Mar; 61(6):2429-33. PubMed ID: 11289110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of nuclear estrogen receptors induced by low-power laser irradiation via PI3-K/Akt signaling cascade.
    Huang L; Tang Y; Xing D
    J Cell Physiol; 2013 May; 228(5):1045-59. PubMed ID: 23065720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stimulated PI3K-AKT signaling mediated through ligand or radiation-induced EGFR depends indirectly, but not directly, on constitutive K-Ras activity.
    Toulany M; Baumann M; Rodemann HP
    Mol Cancer Res; 2007 Aug; 5(8):863-72. PubMed ID: 17699110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AKT and MET signalling mediates antiapoptotic radioresistance in head neck cancer cell lines.
    Ettl T; Viale-Bouroncle S; Hautmann MG; Gosau M; Kölbl O; Reichert TE; Morsczeck C
    Oral Oncol; 2015 Feb; 51(2):158-63. PubMed ID: 25499462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spatial relationship of phosphorylated epidermal growth factor receptor and activated AKT in head and neck squamous cell carcinoma.
    Nijkamp MM; Hoogsteen IJ; Span PN; Takes RP; Lok J; Rijken PF; van der Kogel AJ; Bussink J; Kaanders JH
    Radiother Oncol; 2011 Oct; 101(1):165-70. PubMed ID: 21775008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential activation of the phosphatidylinositol 3'-kinase/Akt survival pathway by ionizing radiation in tumor and primary endothelial cells.
    Zingg D; Riesterer O; Fabbro D; Glanzmann C; Bodis S; Pruschy M
    Cancer Res; 2004 Aug; 64(15):5398-406. PubMed ID: 15289348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fak/Src signaling in human intestinal epithelial cell survival and anoikis: differentiation state-specific uncoupling with the PI3-K/Akt-1 and MEK/Erk pathways.
    Bouchard V; Demers MJ; Thibodeau S; Laquerre V; Fujita N; Tsuruo T; Beaulieu JF; Gauthier R; Vézina A; Villeneuve L; Vachon PH
    J Cell Physiol; 2007 Sep; 212(3):717-28. PubMed ID: 17443665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human intestinal epithelial crypt cell survival and death: Complex modulations of Bcl-2 homologs by Fak, PI3-K/Akt-1, MEK/Erk, and p38 signaling pathways.
    Harnois C; Demers MJ; Bouchard V; Vallée K; Gagné D; Fujita N; Tsuruo T; Vézina A; Beaulieu JF; Côté A; Vachon PH
    J Cell Physiol; 2004 Feb; 198(2):209-22. PubMed ID: 14603523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.